{
  "case_id": "case_0002",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 27.61,
    "sex": "Female",
    "genderIdentity": "Non-binary",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- right cerebellum and left optic nerve (cranial nerve II).\n  \nRemaining signs are better explained by:\n- right T7 spinal cord lesion\n\nThan the suggested:\n- left paracentral lobule.",
      "structured_data": {
        "gt_lesions_english": [
          "right T7 myelopathy",
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "cerebellar hemisphere",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "paracentral lobule",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [
          "right T7 myelopathy"
        ],
        "additional_lesions_in_ft": [
          "left paracentral lobule"
        ]
      },
      "scoring": {
        "gt_lesion_count": 3,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 1,
        "additional_lesion_count": 1,
        "proportion_correct": 0.6666666666666666,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.3333333333333333,
        "proportion_additional": 0.3333333333333333
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD); Neuromyelitis optica spectrum disorder (AQP4-IgG positive); CNS sarcoidosis; Primary CNS vasculitis; Vitamin B12 deficiency; Ischaemic cerebellar stroke",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting multiple sclerosis",
          "Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "CNS sarcoidosis",
          "Primary CNS vasculitis",
          "Vitamin B12 deficiency",
          "Ischaemic cerebellar stroke"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Palpitations": "comorbidity",
          "Gallstones": "comorbidity",
          "Confusional arousal": "comorbidity",
          "Group B strep": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Palpitations",
          "Gallstones",
          "Confusional arousal",
          "Group B strep"
        ],
        "additional_diagnoses": [
          "Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "CNS sarcoidosis",
          "Primary CNS vasculitis",
          "Vitamin B12 deficiency",
          "Ischaemic cerebellar stroke"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Brain; Thoracic Spine, and Orbits and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI brain and orbits with gadolinium",
          "MRI cervical and thoracic spine with gadolinium",
          "Lumbar puncture with CSF analysis including cell count, protein, glucose, oligoclonal bands, and IgG index",
          "Visual evoked potentials",
          "Optical coherence tomography",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Vitamin B12",
          "Serum folate",
          "Thyroid-stimulating hormone",
          "Serum vitamin D",
          "Serum ACE",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Aquaporin-4 IgG (cell-based assay)",
          "MOG-IgG (cell-based assay)",
          "HIV 1/2 antigen/antibody",
          "Hepatitis B surface antigen",
          "Hepatitis C antibody",
          "Syphilis serology",
          "Varicella zoster virus IgG",
          "QuantiFERON-TB Gold",
          "Serum or urine beta-hCG"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 4,
        "found_tests_count": 4,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute disabling relapse with cerebellar ataxia and optic neuritis features",
              "Improves speed of neurological recovery",
              "Low risk once infection is excluded"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastric protection",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroid therapy increases GI risk",
              "Prevention of steroid-induced dyspepsia/ulceration"
            ]
          },
          {
            "treatment": "Physiotherapy and gait/fall-prevention programme",
            "timing": "Start Now",
            "reasons": [
              "Ataxic, unsteady gait",
              "Reduces fall risk and promotes functional recovery"
            ]
          },
          {
            "treatment": "Low-molecular-weight heparin for VTE prophylaxis (unless contraindicated)",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility due to cerebellar ataxia and limb weakness",
              "Prevents deep vein thrombosis"
            ]
          },
          {
            "treatment": "Oral baclofen for spasticity",
            "timing": "Start Now",
            "reasons": [
              "Right lower-limb spasticity and clonus causing functional impairment",
              "Improves comfort and mobility"
            ]
          },
          {
            "treatment": "Plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserve for steroid-refractory acute relapse",
              "Greatest benefit within 2 weeks if inadequate response to steroids"
            ]
          },
          {
            "treatment": "High-efficacy disease-modifying therapy for MS (e.g., ocrelizumab or natalizumab, per eligibility)",
            "timing": "Delay",
            "reasons": [
              "Initiate after confirmation of MS by MRI/CSF per McDonald criteria",
              "Requires infection screening, vaccination review, and risk stratification (e.g., JCV)"
            ]
          },
          {
            "treatment": "Vitamin D supplementation",
            "timing": "Start Now",
            "reasons": [
              "Safe and commonly deficient; deficiency is associated with MS activity",
              "Bone protection during and after corticosteroid use"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute disabling relapse with cerebellar ataxia and optic neuritis features",
              "Improves speed of neurological recovery",
              "Low risk once infection is excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "High-efficacy disease-modifying therapy for MS (e.g., ocrelizumab or natalizumab, per eligibility)",
            "timing": "Delay",
            "reasons": [
              "Initiate after confirmation of MS by MRI/CSF per McDonald criteria",
              "Requires infection screening, vaccination review, and risk stratification (e.g., JCV)"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 1,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.5,
          "proportion_reasons_missed": 0.5
        }
      }
    }
  }
}